{"id":"mometasone-furoate-plus-azelastine-hcl","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Eye irritation"}]},"_chembl":{"chemblId":"CHEMBL1161","moleculeType":"Small molecule","molecularWeight":"521.44"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Mometasone furoate works by inhibiting the release of pro-inflammatory cytokines and mediators, thereby reducing inflammation. Azelastine HCl, on the other hand, blocks histamine receptors, which are involved in allergic responses and inflammation.","oneSentence":"Mometasone furoate is a corticosteroid that reduces inflammation, while azelastine HCl is an antihistamine that blocks histamine receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:12.181Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT05887843","phase":"PHASE1","title":"Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis","status":"TERMINATED","sponsor":"Sandoz","startDate":"2023-06-08","conditions":"Seasonal Allergic Rhinitis","enrollment":38},{"nctId":"NCT03444506","phase":"PHASE2","title":"Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-01-27","conditions":"Seasonal Allergic Rhinitis","enrollment":180},{"nctId":"NCT00720382","phase":"PHASE3","title":"A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Meda Pharmaceuticals","startDate":"2007-03","conditions":"Perennial Allergic Rhinitis","enrollment":703},{"nctId":"NCT01470053","phase":"PHASE3","title":"Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2011-03","conditions":"Perennial Allergic Rhinitis","enrollment":347}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nasaflex Nasal Spray"],"phase":"phase_3","status":"active","brandName":"mometasone furoate plus azelastine HCl","genericName":"mometasone furoate plus azelastine HCl","companyName":"Hanlim Pharm. Co., Ltd.","companyId":"hanlim-pharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone furoate is a corticosteroid that reduces inflammation, while azelastine HCl is an antihistamine that blocks histamine receptors. Used for Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}